ZA949332B - Use of 1-{4-[4-aryl(or heteroaryl)-1-piperazinyl]-butyl}-1H-azole derivatives for the preparation of medicaments intended for the treatment of disorders of gastric secretion - Google Patents

Use of 1-{4-[4-aryl(or heteroaryl)-1-piperazinyl]-butyl}-1H-azole derivatives for the preparation of medicaments intended for the treatment of disorders of gastric secretion

Info

Publication number
ZA949332B
ZA949332B ZA949332A ZA949332A ZA949332B ZA 949332 B ZA949332 B ZA 949332B ZA 949332 A ZA949332 A ZA 949332A ZA 949332 A ZA949332 A ZA 949332A ZA 949332 B ZA949332 B ZA 949332B
Authority
ZA
South Africa
Prior art keywords
piperazinyl
heteroaryl
aryl
butyl
treatment
Prior art date
Application number
ZA949332A
Other languages
English (en)
Inventor
Jordi Frigoa-Constansa
Ramon Merce-Vidal
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Publication of ZA949332B publication Critical patent/ZA949332B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
ZA949332A 1993-11-25 1994-11-24 Use of 1-{4-[4-aryl(or heteroaryl)-1-piperazinyl]-butyl}-1H-azole derivatives for the preparation of medicaments intended for the treatment of disorders of gastric secretion ZA949332B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9314102A FR2712808B1 (fr) 1993-11-25 1993-11-25 Utilisation des dérivés de 1-{4-[4-aryl(ou hétéroaryl)-1-pipérazinyl]-butyl}-1-H-azole pour la préparation de médicaments destinés au traitement des troubles de la sécrétion gastrique .

Publications (1)

Publication Number Publication Date
ZA949332B true ZA949332B (en) 1995-11-14

Family

ID=9453220

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA949332A ZA949332B (en) 1993-11-25 1994-11-24 Use of 1-{4-[4-aryl(or heteroaryl)-1-piperazinyl]-butyl}-1H-azole derivatives for the preparation of medicaments intended for the treatment of disorders of gastric secretion

Country Status (10)

Country Link
US (1) US5532234A (xx)
EP (1) EP0655248B1 (xx)
JP (1) JPH07242626A (xx)
AT (1) ATE184485T1 (xx)
AU (1) AU674458B2 (xx)
CA (1) CA2136661A1 (xx)
DE (1) DE69420679D1 (xx)
ES (1) ES2089974B1 (xx)
FR (1) FR2712808B1 (xx)
ZA (1) ZA949332B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5712392A (en) 1990-12-28 1998-01-27 Neurogen Corporation Certain 4-piperidine- and piperazinoalkyl-2-phenyl imidazole derivatives; dopamine receptor subtype specific ligands
US5681956A (en) * 1990-12-28 1997-10-28 Neurogen Corporation 4-aryl substituted piperazinylmethyl phenylimidazole derivatives; a new class of dopamine receptor subtype specific ligands
WO1997003058A1 (fr) * 1995-07-07 1997-01-30 Taisho Pharmaceutical Co., Ltd. Derives de 4-alkylthiazoline
FR2763950B1 (fr) * 1997-06-02 2002-09-20 Esteve Labor Dr 2- {4- [4-(4,5-dichloro-2-methylimidazol-1-yl)butyl] -1- piperazinyl }-5-fluoropyrimidine, sa preparation et son utilisation therapeutique
US6166205A (en) * 1998-09-02 2000-12-26 Neurogen Corporation 2-Aryl-4-(1-[4-heteroaryl]piperazin-1-yl)methylimidazoles: dopamine . D.sub4 receptor subtype ligands
EP1165013A4 (en) * 1999-03-03 2002-08-07 Merck & Co Inc PRENYL PROTEIN TRANSFERASE INHIBITORS
US7332494B2 (en) 2000-08-14 2008-02-19 Janssen Pharmaceutica, N.V. Method for treating allergies using substituted pyrazoles
WO2002014315A2 (en) 2000-08-14 2002-02-21 Ortho Mcneil Pharmaceutical, Inc. Substituted pyrazoles
CN1329392C (zh) 2000-08-14 2007-08-01 奥索-麦克尼尔药品公司 取代的吡唑
DK1309592T3 (da) 2000-08-14 2006-08-21 Ortho Mcneil Pharm Inc Substituerede pyrazoler
US6369032B1 (en) 2000-09-06 2002-04-09 Ortho-Mcneil Pharmaceutical, Inc. Method for treating allergies
GB2435827A (en) * 2006-03-09 2007-09-12 Del Dr Esteve S A Spain Lab Use of substituted piperazine compounds for the treatment of food related disorders
JP2016500084A (ja) * 2012-11-26 2016-01-07 リアオニン エミー バイオロジカル ファーマシューティカル カンパニー リミテッドＬｉａｏｎｉｎｇ Ｅｍｍｙ Ｂｉｏｌｏｇｉｃａｌ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｃｏ．，Ｌｔｄ 含窒素ベンゾ複素五員環基ピペリジン又はピペラジン誘導体及びその作製方法並びに薬剤組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2672052B1 (fr) * 1991-01-28 1995-05-24 Esteve Labor Dr Derives d'aryl (ou heteroaryl)-piperazinyl-alkyl-azoles, leur preparation et leur application en tant que medicaments.
US5096908A (en) * 1990-05-04 1992-03-17 Eli Lilly And Company Method of inhibiting gastric acid secretion

Also Published As

Publication number Publication date
AU7900794A (en) 1995-06-01
FR2712808B1 (fr) 1996-02-16
FR2712808A1 (fr) 1995-06-02
ES2089974A1 (es) 1996-10-01
AU674458B2 (en) 1996-12-19
ATE184485T1 (de) 1999-10-15
US5532234A (en) 1996-07-02
JPH07242626A (ja) 1995-09-19
ES2089974B1 (es) 1997-03-16
EP0655248B1 (fr) 1999-09-15
EP0655248A1 (fr) 1995-05-31
CA2136661A1 (fr) 1995-05-26
DE69420679D1 (de) 1999-10-21

Similar Documents

Publication Publication Date Title
IL109578A0 (en) Nor-bile acid derivatives, processes for their preparation and the use of these compounds as medicaments
AU621483B2 (en) Azaindenes
BG106095A (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
AU599792B2 (en) Anti-parkinsonian indolone derivatives
AU4732989A (en) Pyrimidines and their pharmaceutical acceptable salts thereof, and their use as medicines
HU9600834D0 (en) Quinazoline derivatives
AU1625192A (en) Heterocyclic derivatives
ZA949332B (en) Use of 1-{4-[4-aryl(or heteroaryl)-1-piperazinyl]-butyl}-1H-azole derivatives for the preparation of medicaments intended for the treatment of disorders of gastric secretion
GR3019388T3 (en) The use of buspirone for preparing a pharmaceutical composition for the treatment of alcohol abuse
AU8296987A (en) Pharmaceutical composition comprising fluticasone propionate
HUT56494A (en) Process for producing pharmaceutical compositions suitable for peroral administration of pimobendane
GB9113628D0 (en) Heterocyclic derivatives
GB9310095D0 (en) Therapeutic compounds
EP0535250A4 (en) Novel compounds and use thereof as medicine
PL322284A1 (en) Derivatives of aminoteralin useful in treating diseases of cardiovascular system
IL92233A0 (en) 1,2,3,4-tetrahydro-1,9-acridinediamines,a process for their preparation and their use as pharmaceutical compositions
AU3934689A (en) New furylthiazole derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
WO2001046178A3 (en) Substituierte bisindolymaleimide
TW207497B (xx)
NO933521D0 (no) Acylsulfonamido- og sulfonamidopyridin-2-karboksylsyreester samt deres pyridin-n-oksyder, fremgangsmaater for deres fremstilling og deres anvendelse som legemiddel
WO1999019324A3 (en) Antipsychotic substituted piperidine derivatives
EP0301239A3 (en) Use of gepirone for preparing pharmaceutical compositions for alleviation of panic disorders
GR3037039T3 (en) Use of trimetazidine for the preparation of medicaments for the treatment of troubles due to the therapeutical use of immunosuppressants.
MXPA99003849A (es) Derivados 9a, 11b-deshidro de 9-oxima-3-ceto-6-0-metileritromicina.
AU580050B2 (en) Triazolopyrimidine derivatives